For example, in patients with pathogenic de novo variants in the TP53 gene, causing Li-Fraumeni syndrome (LFS), a family history of cancers suggesting the LFS diagnosis will be absent [5]. This evidence concerns the gene TP53 and Li-Fraumeni syndrome.